Oxaliplatin-Based Chemotherapy in Advanced Neuroendocrine Tumors: Clinical Outcomes and Preliminary Correlation with Biological Factors

Publisher： Karger

E-ISSN： 1423-0194|103|6|806-814

ISSN： 0028-3835

Source： Neuroendocrinology, Vol.103, Iss.6, 2016-01, pp. : 806-814

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Risk Factors for Disease Progression in Advanced Jejunoileal Neuroendocrine Tumors

By  

Neuroendocrinology, Vol. 96, Iss. 1, 2011-12 ,pp. : 32-40

Karger

Access to resources Recommend Favorite

Translation of Molecular Pathways into Clinical Trials of Neuroendocrine Tumors

By  

Neuroendocrinology, Vol. 97, Iss. 1, 2012-04 ,pp. : 99-112

Karger

Access to resources Recommend Favorite

Clinical and Prognostic Features of Rectal Neuroendocrine Tumors

By  

Neuroendocrinology, Vol. 98, Iss. 3, 2013-11 ,pp. : 180-187

Karger

Access to resources Recommend Favorite

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Chemotherapy in Patients with Neuroendocrine Tumors

By  

Neuroendocrinology, Vol. 90, Iss. 2, 2009-08 ,pp. : 214-219

Karger

Access to resources Recommend Favorite

Temozolomide in Advanced Neuroendocrine Neoplasms: Pharmacological and Clinical Aspects

By  

Neuroendocrinology, Vol. 101, Iss. 4, 2015-04 ,pp. : 274-288

Karger

Access to resources Recommend Favorite